ArticleBMC complementary medicine and therapies2026
Preparation, characterization and evaluation of microemulsions containing Clausena excavata Burm. f. leaf essential oil.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsClausena excavataBurm. f. (Rutaceae), a tropical plant widely used in traditional medicine, contains bioactive compounds, including essential oils with antibacterial and anti-inflammatory effects. This study explored the development of microemulsions to increase antibacterial activity and reduce the toxicity of C. excavata leaf essential oils.
methodsC. excavata leaf essential oil was extracted via hydrodistillation, and its chemical composition was analyzed via gas chromatography-mass spectrometry (GC-MS). Microemulsions (F1-F8) were prepared based on pseudoternary phase diagrams. Following thermodynamic stability testing, four formulations (F1-F4) containing Tween® 80 and ethanol (1:1–4:1) were selected. Among these, F1 and F2 were chosen for optimization into oral spray formulations due to their superior antibacterial activity. Paraben was incorporated as a preservative agent.
resultsThese microemulsions exhibited desirable droplet sizes of 11–13 nm, low polydispersity index values, and pH values of 5.8–6.2. The antibacterial activity, evaluated via MIC and MBC assays, revealed that compared with the pure essential oil, microemulsion F1 had significantly lower MIC values 16 and 12 times lower against Streptococcus pyogenes and Klebsiella pneumoniae, respectively (p < 0.05). Moreover, the microemulsion retained anti-inflammatory activity against RAW264.7 cells. Safety assessments via the MTT assay in oral squamous carcinoma cells demonstrated that the microemulsion was less toxic than the pure essential oil.
conclusionThese findings suggest that the incorporation of C. excavata leaf essential oil into a microemulsion system enhances its efficacy and safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.